drugset / Trial / NCT00501683

A Single Dose Of GSK189075 Taken By Mouth Containing Small Amounts Of Radioactivity Studied In Healthy Male Volunteers

NCT00501683

Phase 1 Completed 8 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will look at the relative amounts of GSK189075 that are found in samples of blood, urine, and feces of healthy male volunteers. Results of the study will be used to understand how the drug is converted in the body and how it is eliminated.

Timeline

Start
2006-11
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject remogliflozin etabonate Small molecule 400 mg Oral